PortfoliosLab logoPortfoliosLab logo
SGMO vs. DERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SGMO vs. DERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sangamo Therapeutics, Inc. (SGMO) and Journey Medical Corporation (DERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


SGMO

1D
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*

DERM

1D
-1.24%
1M
-10.16%
6M
-23.80%
YTD
-17.38%
1Y
-8.87%
3Y*
49.15%
5Y*
10Y*
ALL TIME*
-6.40%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$945.23K$1.03M$1.67M

SGMO vs. DERM - Yearly Performance Comparison


2026 (YTD)20252024202320222021
SGMO
Sangamo Therapeutics, Inc.
-82.38%-58.82%87.74%-82.70%-58.13%-25.30%
DERM
Journey Medical Corporation
-17.38%97.19%-32.12%200.00%-64.31%-38.16%

Correlation

The correlation between SGMO and DERM is 0.08, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.08

Correlation (3Y)
Balances recent behavior with more history.

0.11

Correlation (All Time)
Calculated using the full available price history since Nov 12, 2021

0.10

Fundamentals

Market Cap

SGMO:

$30.66M

DERM:

$175.31M

EPS

SGMO:

-$0.36

DERM:

-$0.37

PS Ratio

SGMO:

0.74

DERM:

2.52

Total Revenue (TTM)

SGMO:

$34.56M

DERM:

$64.68M

Gross Profit (TTM)

SGMO:

$25.51M

DERM:

$28.33M

EBITDA (TTM)

SGMO:

-$106.29M

DERM:

-$2.87M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SGMO vs. DERM — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SGMO

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


DERM
DERM Risk / Return Rank: 3636
Overall Rank
DERM Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
DERM Sortino Ratio Rank: 3737
Sortino Ratio Rank
DERM Omega Ratio Rank: 3838
Omega Ratio Rank
DERM Calmar Ratio Rank: 3636
Calmar Ratio Rank
DERM Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SGMO vs. DERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sangamo Therapeutics, Inc. (SGMO) and Journey Medical Corporation (DERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SGMODERMDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.02

Calmar ratioReturn relative to maximum drawdown

-0.25

Martin ratioReturn relative to average drawdown

-0.54

SGMO vs. DERM - Sharpe Ratio Comparison


Loading charts...

Drawdowns

SGMO vs. DERM - Drawdown Comparison


Loading charts...

Drawdown Indicators


SGMODERMDifference

Max Drawdown

Largest peak-to-trough decline

-89.11%

Max Drawdown (1Y)

Largest decline over 1 year

-52.59%

Max Drawdown (3Y)

Largest decline over 3 years

-63.32%

Current Drawdown

Current decline from peak

-32.95%

Average Drawdown

Average peak-to-trough decline

-49.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.61%

Volatility

SGMO vs. DERM - Volatility Comparison


Loading charts...

Volatility by Period


SGMODERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.23%

Volatility (6M)

Calculated over the trailing 6-month period

54.53%

Volatility (1Y)

Calculated over the trailing 1-year period

65.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

89.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

89.89%

Dividends

SGMO vs. DERM - Dividend Comparison

Neither SGMO nor DERM has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SGMO vs. DERM - Financials Comparison

This section allows you to compare key financial metrics between Sangamo Therapeutics, Inc. and Journey Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


SGMO and DERM have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for SGMO and DERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer